Soluble cd44 variants in the serum of patients with urological malignancies

Oncology (Switzerland)

Volumn 54, Issue 3, 1997, Pages 226-230

  Lein, Michael ^a   Jung, Klaus ^a   Weiss, Susanne ^a   Schnorr, Dietmar ^a   Loening, Stefan A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Carcinoma immunology; CD44; Cell adhesion molecules; Tumor markers

Indexed keywords

HERMES ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLADDER CANCER; CANCER IMMUNOLOGY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; URINARY TRACT CANCER;

EID: 0030892598     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227693     Document Type: Article

References (29)

1. Ponta H, Slccman J, Herrlich P: Tumor metastasis formation: Cell-surface proteins confer metastasis-promoting or -suppressing properties, Biochim Biophys Acta 1994:1198:1-10.
2. Stetler Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis, Annu Rev Cell Biol 1993;9:541-573.
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate, Cell 1990:61: 1303-1313.
4. Albelda SM: Role of integrins and other cell adhesion molcculcs in tumor progression and metastasis, Lab Invest 1993:68:4-17.
5. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor, Comparison of all 10 variable exons between mouse, human, and rat, J Biol Chem 1993:268:12235-12238.
6. Tolg C, Hofmann M, Herrlich P, Ponta H: Splicing choicc from ten variant exons establishes CD44 variability, Nucleic Acids Res 1993:21:1225-1229.
7. Stamenkovic I, Aruffo A, Aminot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potential for hyaluronate bearing cells, EMBOJ 1991:10:343-348.
8. Heider KH, Hofmann M, Hors H, van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps, J Cell Biol 1993:120:227-233.
9. Dali P, Heider KH, Hekele A, von Minckwitz G, Kaufmann M, Ponta H, Herrlich P: Surface protein expression and messenger RNA-splic-ing analysis of CD44 in uterine cervical cancer and normal cervical epithelium, Cancer Res 1994;54:3337-3341.
10. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Hcrrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression, Cancer Res 1993;53:4754-4756.
11. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U: CD44 splice variants confer metastatic behavior in rats: Homologous sequences arc expressed in human tumor cell lines, Cancer Res 1991;51:5292-5297.
12. Liu AY: Expression of CD44 in prostate cancer cells, CanccrLett 1994;76:63-69.
13. Hong RL, Pu YS, Chu JS, Lee WJ, Chen YC, Wu CW: Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma, Cancer Lett 1995;89:81-87.
14. Guo YJ, Liu G, Wang X, Jin D, Wu M, Ma J, Sy MS: Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer, Cancer Res 1994;54:422-426.
15. Sliutz G, Tempfcr C, Winkler S, Kohlbergcr P, Reinthaller A, KainzC: Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer, Br J Cancer 1995;72:1494-1497.
16. Kainz C, Tempfer C, Winkler S, Sliutz G, Koclbl H, Reinthaller A: Serum CD44 splicc variants in cervical cancer patients, Cancer Lett 1995;90:231-234.
17. Harn HJ, Ho LI, Shyu RY, Yuan JS, Lin FG, Young TH, Liu CA, Tang HS, Lee WH: Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma, J Clin Gastroenterol 1996;22:107-110.
18. Kitt EM, Ruckscr R, Huber K, Sclleny S, Wo-roffka B, Hoffmann J, Weichselbaum J, Ogris E, Hinterberger W, Bauer K: CD44 Standard and the Varianten (v5) and (v6) bei Mammakarzinom, Lab Med 1995;19:103-106.
19. Katoh S, McCarthy JB, Kincade PW: Characterization of soluble CD44 in the circulation of mice, Levels arc affected by immune activity and tumor growth, J Immunol 1994:153:3440-3449.
20. Bourguignon LYW, Iida N, Welsh CF, Kron-gard A, Pasquale D: Involvement of CD44 and its variant isoforms in membrane cytoskeleton interaction, cell adhesion and tumor metastasis, J Neurooncol 1995;26:201-208.
21. Bazil V, Strominger JL: Metalloprotease and serine proteasc arc involved in cleavage of CD43, CD44, and CD 16 from stimulated human granulocytes, Induction of cleavage of L-selcctin via CD 16, J Immunol 1994; 152:1314-1322.
22. Hathorn RW, Tso CL, Kaboo R, Pang S, Figlin R, Saw'yers C, Dckemion JB, Belldegrun A: In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer, Cancer 1994;74:1904-1911.
23. Bazil V, Horejsi V: Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the efTect of a natural receptor ligand, J Immunol 1992;149:747-753.
24. Sherman L, Slccman J, Herrlich P, Ponta H: Hyaluronate receptors: Key players in growth, differentiation, migration and tumor progression, CurrOpin Cell Biol 1994;6:726-733.
25. Ponta H, Sleeman J, Dali P, Moll J, Sherman L, Herrlich P: CD44 isoforms in metastatic cancer, Invasion Metastasis 1995:14:82-86.
26. Gansauge F, Gansauge S, Poch B, Scheiblich A, Bcgcr HG: Soluble CD44v6: A prognostic parameter in pancreatic cancer, Langcnbeck 1996;suppl:519-522.
27. Dali P, Heider KH, Sinn HP, Skroch Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast canccr, Int J Cancer 1995:60:471-477.
28. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation (sec comments), Lancet 1992:340: 1053-1058.
29. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL, Rosada C: Expression of CD44 in human lung tumors, Cancer Res 1994:54:1381-1387.